Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miroslav Havranek

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 8, 2007
Novel selective PPARdelta agonists: optimization of activity by modification of alkynylallylic moietyMiroslav Havranek, Per Sauerberg, John P Mogensen, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2007
Design of a partial PPARdelta agonistIngrid Pettersson, Søren Ebdrup, Miroslav Havranek, et al.
Bioorganic & Medicinal Chemistry Letters|March 24, 2007
Design of potent PPARalpha agonistsPer Sauerberg, John P Mogensen, Lone Jeppesen, et al.
Journal of Medicinal Chemistry|March 9, 2007
Identification and synthesis of a novel selective partial PPARdelta agonist with full efficacy on lipid metabolism in vitro and in vivoPer Sauerberg, Grith S Olsen, Lone Jeppesen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|June 8, 2007
Novel selective PPARdelta agonists: optimization of activity by modification of alkynylallylic moietyMiroslav Havranek, Per Sauerberg, John P Mogensen, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2007
Design of a partial PPARdelta agonistIngrid Pettersson, Søren Ebdrup, Miroslav Havranek, et al.
Bioorganic & Medicinal Chemistry Letters|March 24, 2007
Design of potent PPARalpha agonistsPer Sauerberg, John P Mogensen, Lone Jeppesen, et al.
Journal of Medicinal Chemistry|March 9, 2007
Identification and synthesis of a novel selective partial PPARdelta agonist with full efficacy on lipid metabolism in vitro and in vivoPer Sauerberg, Grith S Olsen, Lone Jeppesen, et al.
Pageof 1